123 related articles for article (PubMed ID: 35676639)
1. Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain).
Giner-Soriano M; Gomez-Lumbreras A; Vedia C; Ouchi D; Morros R
BMC Prim Care; 2022 Jun; 23(1):147. PubMed ID: 35676639
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
Rivera-Caravaca JM; Núñez-Gil IJ; Vivas D; Viana-Llamas MC; Uribarri A; Becerra-Muñoz VM; Trabattoni D; Fernández Rozas I; Feltes G; López-Pais J; El-Battrawy I; Macaya C; Fernandez-Ortiz A; Estrada V; Marín F;
Eur J Clin Invest; 2021 Jan; 51(1):e13436. PubMed ID: 33080051
[TBL] [Abstract][Full Text] [Related]
3. The use and adherence of oral anticoagulants in Primary Health Care in Catalunya, Spain: A real-world data cohort study.
Giner-Soriano M; Cortes J; Gomez-Lumbreras A; Prat-Vallverdú O; Quijada-Manuitt MA; Morros R
Aten Primaria; 2020 Oct; 52(8):529-538. PubMed ID: 32788057
[TBL] [Abstract][Full Text] [Related]
4. Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities.
Rieder M; Gauchel N; Kaier K; Jakob C; Borgmann S; Classen AY; Schneider J; Eberwein L; Lablans M; Rüthrich M; Dolff S; Wille K; Haselberger M; Heuzeroth H; Bode C; von Zur Mühlen C; Rieg S; Duerschmied D
Clin Res Cardiol; 2022 Mar; 111(3):322-332. PubMed ID: 34546427
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study.
Arachchillage DJ; Rajakaruna I; Odho Z; Crossette-Thambiah C; Nicolson PLR; Roberts LN; Allan C; Lewis S; Riat R; Mounter P; Lynch C; Langridge A; Oakes R; Aung N; Drebes A; Dutt T; Raheja P; Delaney A; Essex S; Lowe G; Sutton D; Lentaigne C; Sayar Z; Kilner M; Everington T; Shapiro S; Alikhan R; Szydlo R; Makris M; Laffan M
Br J Haematol; 2022 Jan; 196(1):79-94. PubMed ID: 34500500
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic.
Ouchi D; Vilaplana-Carnerero C; de Dios V; Giner-Soriano M; Morros R
Prim Care Diabetes; 2022 Dec; 16(6):753-759. PubMed ID: 36216752
[TBL] [Abstract][Full Text] [Related]
7. Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study.
Altaraihi S; Kamstrup P; Eklöf J; Dyrby Johansen N; Biering-Sørensen T; Sivapalan P; Jensen JU
ERJ Open Res; 2023 May; 9(3):. PubMed ID: 37228282
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study.
Lau WCY; Douglas IJ; Wong ICK; Smeeth L; Lip GYH; Leung WK; Siu CW; Cheung BMY; Mok MTC; Chan EW
Heart Rhythm; 2020 Jan; 17(1):33-40. PubMed ID: 31377423
[TBL] [Abstract][Full Text] [Related]
9. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain.
Roel E; Pistillo A; Recalde M; Fernández-Bertolín S; Aragón M; Soerjomataram I; Jenab M; Puente D; Prieto-Alhambra D; Burn E; Duarte-Salles T
Int J Cancer; 2022 Mar; 150(5):782-794. PubMed ID: 34655476
[TBL] [Abstract][Full Text] [Related]
10. Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection.
Lachant DJ; Lachant NA; Kouides P; Rappaport S; Prasad P; White RJ
J Thromb Haemost; 2020 Oct; 18(10):2640-2645. PubMed ID: 33448631
[TBL] [Abstract][Full Text] [Related]
11. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
12. Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients - A retrospective cohort study on 5392 patients from a tertiary centre.
Bistrovic P; Sabljic A; Kovacevic I; Cikara T; Keres T; Lucijanic T; Mitrovic J; Delic-Brkljacic D; Manola S; Lucijanic M
Int J Cardiol; 2023 Feb; 372():144-149. PubMed ID: 36471534
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients?
Covino M; De Matteis G; Della Polla D; Burzo ML; Pascale MM; Santoro M; De Cristofaro R; Gasbarrini A; De Candia E; Franceschi F
Aging Clin Exp Res; 2021 Aug; 33(8):2335-2343. PubMed ID: 34216379
[TBL] [Abstract][Full Text] [Related]
15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
16. Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.
Raventós B; Pistillo A; Reyes C; Fernández-Bertolín S; Aragón M; Berenguera A; Jacques-Aviñó C; Medina-Perucha L; Burn E; Duarte-Salles T
BMJ Open; 2022 Apr; 12(4):e057866. PubMed ID: 35396302
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-related thrombotic complications experience before and during delta wave.
Manzur-Pineda K; O'Neil CF; Bornak A; Lalama MJ; Shao T; Kang N; Kennel-Pierre S; Tabbara M; Velazquez OC; Rey J
J Vasc Surg; 2022 Nov; 76(5):1374-1382.e1. PubMed ID: 35700857
[TBL] [Abstract][Full Text] [Related]
18. Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study.
Matli K; Chamoun N; Fares A; Zibara V; Al-Osta S; Nasrallah R; Salameh P; Mokhbat J; Ghanem G
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34611018
[TBL] [Abstract][Full Text] [Related]
19. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
Lund LC; Kristensen KB; Reilev M; Christensen S; Thomsen RW; Christiansen CF; Støvring H; Johansen NB; Brun NC; Hallas J; Pottegård A
PLoS Med; 2020 Sep; 17(9):e1003308. PubMed ID: 32898149
[TBL] [Abstract][Full Text] [Related]
20. The association between anticoagulation and adverse outcomes after a positive SARS-CoV-2 test among older outpatients: A population-based cohort study.
Abdel-Qadir H; Austin PC; Pang A; Fang J; Udell JA; Geerts WH; McNaughton CD; Jackevicius CA; Kwong JC; Yeh CH; Cox JL; Lee DS; Ko DT; Atzema CL
Thromb Res; 2022 Mar; 211():114-122. PubMed ID: 35149396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
